Allergy tablet for dust mite rhinitis and asthma
Part of Ear, nose & throat, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 65 years old.
- You have had moderate to severe nasal allergy symptoms (like stuffy or runny nose) for at least 1 year, with or without mild-to-moderate asthma.
- You tested positive for dust mite allergy through a skin test or IgE blood test.
- You have a smartphone to track your symptoms and medicine use.
- You can commit to a specific birth control method if you are a woman of childbearing age.
- You are not allergic to other things (like mold, cockroach, or certain pollens) that might interfere with the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.